John Overdeck’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.39M | Sell |
39,497
-1,009
| -2% | -$186K | 0.01% | 1777 |
|
|
2026
Q1 | $7.64M | Sell |
40,506
-149,424
| -79% | -$31.5M | 0.01% | 1626 |
|
|
2025
Q4 | $37.7M | Buy |
189,930
+123,360
| +185% | +$24.9M | 0.05% | 438 |
|
|
2025
Q3 | $13.5M | Buy |
66,570
+45,953
| +223% | +$8.15M | 0.02% | 806 |
|
|
2025
Q2 | $3.63M | Sell |
20,617
-5,233
| -20% | -$788K | 0.01% | 1438 |
|
|
2025
Q1 | $3.48M | Sell |
25,850
-232,093
| -90% | -$30.6M | 0.01% | 1345 |
|
|
2024
Q4 | $32.6M | Buy |
257,943
+147,731
| +134% | +$22M | 0.07% | 344 |
|
|
2024
Q3 | $18.3M | Buy |
110,212
+95,612
| +655% | +$14.5M | 0.04% | 521 |
|
|
2024
Q2 | $1.94M | Buy |
+14,600
| New | +$1.76M | ﹤0.01% | 1567 |
|
|
2024
Q1 | – | Sell |
-28,500
| Closed | -$2.15M | – | 3389 |
|
|
2023
Q4 | $2.15M | Sell |
28,500
-5,330
| -16% | -$338K | ﹤0.01% | 1481 |
|
|
2023
Q3 | $2.23M | Buy |
33,830
+3,900
| +13% | +$292K | 0.01% | 1309 |
|
|
2023
Q2 | $2.44M | Buy |
29,930
+2,830
| +10% | +$201K | 0.01% | 1305 |
|
|
2023
Q1 | $1.61M | Buy |
27,100
+14,070
| +108% | +$782K | ﹤0.01% | 1544 |
|
|
2022
Q4 | $636K | Buy |
+13,030
| New | +$602K | ﹤0.01% | 1920 |
|
|
2022
Q2 | – | Sell |
-4,330
| Closed | -$372K | – | 2929 |
|
|
2022
Q1 | $372K | Buy |
4,330
+761
| +21% | +$62.5K | ﹤0.01% | 2141 |
|
|
2021
Q4 | $292K | Sell |
3,569
-23,035
| -87% | -$1.68M | ﹤0.01% | 3662 |
|
|
2021
Q3 | $1.77M | Buy |
26,604
+21,747
| +448% | +$1.54M | ﹤0.01% | 2107 |
|
|
2021
Q2 | $325K | Sell |
4,857
-119,319
| -96% | -$7.4M | ﹤0.01% | 3450 |
|
|
2021
Q1 | $6.46M | Sell |
124,176
-83,308
| -40% | -$4.21M | 0.02% | 914 |
|
|
2020
Q4 | $8.29M | Buy |
+207,484
| New | +$6.7M | 0.02% | 672 |
|
|
2020
Q2 | – | Sell |
-253,007
| Closed | -$3.64M | – | 3516 |
|
|
2020
Q1 | $3.64M | Sell |
253,007
-154,043
| -38% | -$4.42M | 0.03% | 651 |
|
|
2019
Q4 | $15.5M | Buy |
407,050
+383,691
| +1,643% | +$11.5M | 0.05% | 448 |
|
|
2019
Q3 | $517K | Buy |
+23,359
| New | +$498K | ﹤0.01% | 2533 |
|
|
2019
Q2 | – | Sell |
-563,175
| Closed | -$16.2M | – | 3666 |
|
|
2019
Q1 | $16.2M | Buy |
563,175
+281,121
| +100% | +$6.94M | 0.05% | 468 |
|
|
2018
Q4 | $4.83M | Buy |
282,054
+267,950
| +1,900% | +$6.49M | 0.02% | 819 |
|
|
2018
Q3 | $401K | Sell |
14,104
-279,808
| -95% | -$9.24M | ﹤0.01% | 2600 |
|
|
2018
Q2 | $9.87M | Buy |
293,912
+17,854
| +6% | +$555K | 0.03% | 674 |
|
|
2018
Q1 | $6.69M | Buy |
+276,058
| New | +$5.5M | 0.02% | 789 |
|
|
2016
Q1 | – | Sell |
-67,104
| Closed | -$1.75M | – | 3123 |
|
|
2015
Q4 | $2.03M | Buy |
+67,104
| New | +$2.2M | 0.01% | 1084 |
|
|
2015
Q3 | – | Sell |
-30,265
| Closed | -$1.75M | – | 2720 |
|
|
2015
Q2 | $1.75M | Buy |
+30,265
| New | +$1.55M | 0.01% | 1287 |
|
|
2013
Q3 | – | Sell |
-77,305
| Closed | -$3.56M | – | 2104 |
|
|
2013
Q2 | $3.56M | Buy |
+77,305
| New | +$3.46M | 0.02% | 650 |
|
Other funds holding THC
GCM
John Overdeck's THC Position: Q2 2026 in Review
John Overdeck reduced its Tenet Healthcare (THC) stake by 2.5% in Q2 2026, selling an estimated $186K and leaving 39,497 shares worth $7.39M. The position accounts for 0.01% of the portfolio, ranked #1777.
John Overdeck first reported a position in THC in Q2 2013 and has held it in 31 quarters since. The position peaked at $37.7M in Q4 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.
- John Overdeck held 39,497 shares of Tenet Healthcare worth $7.39M as of Q2 2026.
- John Overdeck sold 1,009 Tenet Healthcare shares in Q2 2026, an estimated $186K.
- Tenet Healthcare made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1777 holding.
- John Overdeck first reported a position in Tenet Healthcare in Q2 2013 and has held it in 31 quarters since.
- John Overdeck's Tenet Healthcare position peaked at $37.7M in Q4 2025.
- 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.